In this study, several factors influencing the occurrence of active CMV infection after organ
transplantation (Tx) arc analysed. For this purpose, 105 heart, kidney and lung transplant …

The widespread use of antiviral prophylaxis or preemptive therapy among orthotopic liver
transplantation (OLT) recipients has reduced the occurrence of early cytomegalovirus (CMV) …

Background. The incidence and impact of cytomegalovirus (CMV) disease that occurs
despite CMV prophylaxis among liver transplant recipients have been incompletely defined …

Sixty-six patients who had undergone 78 liver transplantations, with no detectable
cytomegalovirus (CMV) infection before transplantation, were studied to assess the value of …

Biopsies collected from gastroduodenal mucosa during endoscopic examination of 20
patients having undergone renal transplantation and subsequent immunosuppressive …

One hundred and forty randomly selected liver transplant recipients were studied before and
after primary orthotopic liver transplantation for the presence or absence of CMV enteritis …

Cytomegalovirus (CMV) is the single most important infectious agent affecting recipients of
organ transplants, with at least two-thirds of these patients having CMV infection 1–4 months …

Not all virus infections are increased following organ transplantation. The most common are
infections by the herpesvirus group, papovavirus (warts and BK virus), hepatitis viruses, and …

Objective: Cytomegalovirus (CMV) immune globulin (CMVIG) has been shown to
significantly reduce severe CMV‐associated disease complicating orthotopic liver transplant …

Fifty-six of 67 patients with antibody to cytomegalovirus before transplantation shed
cytomegalovirus from urine and/or saliva postoperatively. Symptomatic reactivation occurred …